Myocardial Performance Index to assess cardiac function in autoimmune connective tissue disease: a systematic review and meta-analysis
Authors:
- Rudy HidayatRHRudy Hidayat
- Sally Aman NasutionSNSally Aman Nasution
- Faisal ParlindunganFPFaisal Parlindungan
- Naomi Niari DalimuntheNDNaomi Niari Dalimunthe
- Steven AlviantoSASteven Alvianto
- Nicolas Daniel WidjanarkoNWNicolas Daniel Widjanarko
- Ummi KultsumUKUmmi Kultsum
- Cristopher EfendiCECristopher Efendi
- Yovita GotamaYGYovita Gotama
Open Access
- 20 November 2024
- journal article
- research article
- Published by BMJ in Lupus Science & Medicine
- Vol. 11 (2) , e001272
Abstract
Objectives: This study aimed to evaluate cardiac function using Myocardial Performance Index (MPI) in autoimmune connective tissue disease (ACTD) patients without cardiovascular abnormalities.Methods: A systematic search of databases including Medline, Google Scholar, ProQuest, Scopus and Cochrane Library was conducted to identify relevant studies on ACTD and MPI from 1995 to 2023. ACTD included in the search were rheumatoid arthritis (RA), systemic sclerosis (SSc), systemic lupus erythematosus (SLE), Sjögren syndrome (SjD), polymyositis and dermatomyositis. Quality assessment was performed using the Newcastle-Ottawa Scale, followed by meta-analysis computation of mean differences (MDs) of MPI using Review Manager V.5.4.Results: A total of 22 studies for qualitative and 19 for quantitative synthesis were included. We found six studies on RA, eight studies on SSc, five studies on SLE, two studies on SjD and one on mixed connective tissue disorder. Conventional echocardiography and tissue Doppler imaging (TDI) were used to assess the MPI. Both conventional MPI and tissue Doppler MPI values were elevated compared with healthy control (MD=0.11, 95% CI 0.08 to 0.14, p value<0.00001 and MD=0.06, 95% CI 0.03 to 0.10, p value=0.00001, respectively).Conclusions: We found elevated MPI values in patients with ACTD compared with healthy controls. MPI assessment has the potential for early detection and management of cardiac dysfunction in patients with ACTD, but further studies are required to corroborate these findings.PROSPERO registration number: CRD42023490643.Keywords
This publication has 50 references indexed in Scilit:
- A Clinician’s Guide to Tissue Doppler ImagingCirculation, 2006
- Evaluation of Tissue Doppler Tei index for global left ventricular function in mice after myocardial infarction: Comparison with Pulsed Doppler Tei indexEuropean Heart Journal - Cardiovascular Imaging, 2005
- Tissue Doppler Echocardiography and Myocardial Performance Index in Patients with SclerodermaJournal of International Medical Research, 2005
- Impairment of Left Ventricular Function in Systemic Lupus Erythematosus Evaluated by Measuring Myocardial Performance Index with Tissue Doppler EchocardiographyEchocardiography, 2005
- Ventricular function abnormalities in active rheumatoid arthritis: a Doppler echocardiographic studyRheumatology International, 2004
- Novel Approach to Measure Myocardial Performance Index: Pulsed‐Wave Tissue Doppler EchocardiographyEchocardiography, 2003
- Doppler echocardiographic evaluation of ventricular function in patients with rheumatoid arthritisClinical Rheumatology, 2003
- Echocardiographic findings in primary Sjögren’s syndromeAnnals of the Rheumatic Diseases, 1997
- Development of complete heart block in an adult patient with Sjögren's syndrome and anti‐Ro/SS‐A autoantibodiesArthritis & Rheumatism, 1996
- New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function--a study in normals and dilated cardiomyopathy.1995